KUS121

CAS: 1357164-52-3 F: C22H16FN4NaO3S W: 458.44

KUS121, a valosin-containing protein (VCP, p97) modulator with significant neuroprotective effects, attenuates ischemic

Contact QiTai

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity	KUS121, a valosin-containing protein (VCP, p97) modulator with significant neuroprotective effects, attenuates ischemic retinal cell death via suppressing endoplasmic reticulum stress[1][2].
Invitro	KUS121 通过防止ATP耗竭，保护神经元在缺氧和葡萄糖剥夺（OGD）条件下免于细胞死亡。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> KUS121 相关抗体:
In Vivo	KUS121 (IVT injection, 25 μg/eye) 在缺血性损伤后7天和14天似乎表现出更好的内层视网膜变薄抑制效果。KUS121 (IVT injection) 在缺血性损伤后对视网膜形态和功能也具有神经保护作用[1]。KUS121抑制了外核层的变薄并维持了视觉功能。KUS121（视网膜）抑制内质网应激，激活哺乳动物雷帕霉素靶蛋白，并抑制与疾病相关的凋亡[3]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only.
CAS	1357164-52-3
Formula	C22H16FN4NaO3S
Molar Mass	458.44
Appearance	固体
Transport	Room temperature in continental US; may vary elsewhere.
Storage	-20°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Reference	[1]. KUS121, a VCP modulator, attenuates ischemic retinal cell death via suppressing endoplasmic reticulum stress. Sci Rep. 2017 Mar 20:7:44873. [2]. Hisanori Kinoshita, et al. KUS121, a valosin-containing protein modulator, attenuates ischemic stroke via preventing ATP depletion. Sci Rep. 2019 Aug 8;9(1):11519. [3]. Tomoko Hasegawa, et al. Neuoroprotective efficacies by KUS121, a VCP modulator, on animal models of retinal degeneration. Sci Rep. 2016 Aug 9:6:31184.